Skip to content

A Study Comparing Sawangi Flexiforce Expander With That Of NiTi Expander In Treating Posterior Crossbite In Patients From Central India

Comparative Evaluation Of Skeletal And Dentoalveolar Effects Of Sawangi Flexiforce Expander As Against NiTi Expander In Posterior Cross Bite Patients In Central India Population: A Randomised Controlled Trial - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107865
Enrollment
32
Registered
2026-04-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K039- Disease of hard tissues of teeth,unspecified

Interventions

Intervention1: Sawangi Flexiforce Expander: Sawangi Flexiforce Expander will be given to Posterior Crossbite Patients.Duration of intervention will be 39 weeks 28 days Control Intervention1: NiTi Exp

Sponsors

Datta Meghe Institute of Higher Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient with constricted maxilla having posterior crossbite either unilateral or bilateral. 2.Patients with unilateral complete CLP. 3.Patients with Class I or mild Class III malocclusion suitable for transverse maxillary expansion. 4.Patients with age of 7-12 years.

Exclusion criteria

Exclusion criteria: 1.Patient with any other associated syndrome. 2.Patient with history of previous orthodontics. 3.Patient with absence of teeth which supporting the expansion appliance. 4.Patients with a history of any trauma or surgery

Design outcomes

Primary

MeasureTime frame
Sawangi FLexiforce Expander is Anticipated to Show better results compared to NiTi ExpanderTimepoint: Assessment will be done in 32 weeks.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Ranjit Kamble

Datta Meghe Institute Of Higher Education And Research

ranjitkamble2506@gmail.com9822231975

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026